Biotechnology giant Amgen, Inc. (NASDAQ:AMGN) has released positive data for its phase II study showing the efficacy and safety of its pipeline osteoporosis …
Analysts are reiterating buys on Gilead Sciences, Inc. (NASDAQ:GILD) and Amgen, Inc.
